Intel stock spikes after report of possible US government stake
LONDON - BlackRock (NYSE:BLK), Inc. has disclosed an ownership position in Mural Oncology plc, representing 1.64% of the company’s issued share capital, according to a filing with the Irish Takeover Panel dated May 12, 2025. The world’s largest asset manager also reported a 0.41% short position in the same company through cash-settled derivatives.
The disclosure was made under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2022, which mandates that any person holding an interest in relevant securities representing 1% or more must report their holdings. BlackRock’s filing revealed that they control 283,677 ordinary shares of Mural Oncology, with an additional 71,756 shares implicated in cash-settled derivatives.
The announcement comes amid increased scrutiny of investment firms’ positions in companies subject to takeover speculation. While the filing does not indicate any specific intent by BlackRock with respect to Mural Oncology, it is a routine disclosure required by regulatory authorities to ensure transparency in the markets.
No further details of the dealings, such as purchases or sales of shares, were disclosed in the report, except for a transfer out of 522 ordinary shares of Mural Oncology. The form also stated that there are no indemnity or option arrangements, or any agreements or understandings related to the disclosed securities that could be an inducement to deal or refrain from dealing.
Investors and market observers often monitor such disclosures closely as they can provide insights into the strategies of institutional investors like BlackRock. The asset manager’s contact for the disclosure is Jana Blumenstein, available at the provided telephone number.
This filing is a matter of public record and is not indicative of any future acquisition or disposal of securities by BlackRock. The information is based on a press release statement and does not reflect any marketing promotion or endorsement of the claims.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.